Pfizer Inc. (BCBA:PFE)

Argentina flag Argentina · Delayed Price · Currency is ARS
9,730.00
+45.00 (0.46%)
Jan 21, 2026, 2:20 PM BRT
24.27%
Market Cap208.12T
Revenue (ttm)83.41T
Net Income (ttm)13.06T
Shares Outn/a
EPS (ttm)2,293.32
PE Ratio15.94
Forward PE8.64
Dividend340.88 (3.52%)
Ex-Dividend DateNov 7, 2025
Volume15,561
Average Volume31,326
Open9,675.00
Previous Close9,685.00
Day's Range9,620.00 - 9,730.00
52-Week Range5,990.00 - 10,800.00
Beta0.43
RSI50.55
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements